North America Proteomics Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 12.50 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
North America Proteomics Market Analysis
The North American proteomics market is expected to register a CAGR of 12.5% over the forecast period.
Proteomics played a major role during the COVID-19 pandemic. During the pandemic, few market participants made strategic actions, which fueled the market expansion. Numerous proteomic biomarker studies were conducted on COVID-19, including those on proteins of interest that are altered in patients with mild or severe SARS-CoV-2 infections, targeted mass spectrometry-based multiple reaction monitoring (MRM) assays for virus diagnosis, and profiling of plasma/serum and urine proteomics to identify disease pathways. For instance, as per the article published by the Journal of Integrative Biology in January 2022, proteomics is a crucial high-throughput technology platform for gaining a functional overview of how COVID-19 alters host biology. As a result, it can assist in uncovering potential points of entry for innovation in a variety of fields, including pharmaceuticals and vaccines. Hence, the COVID-19 pandemic created a significant impact on the growth of the market and is expected to continue the same over the coming years.
The major factors driving the growth of the market include rising demand for personalized medicine, increasing R&D expenditure, and government funding for proteomics and technological advancements in proteomics.
Proteomics-based molecular diagnostics, protein biochips, and pharmacoproteomics are a few of the innovative medical techniques that have been made possible by advances in proteomic technologies. These innovations have had a significant impact on the development of personalized medicine. For instance, in August 2022, the Clemson University research team developed an open-source model to assist medical researchers in developing scalable prediction models that can represent intricate cellular interactions and permit the integration of sizable datasets, which could be used to advance personalized medicine techniques like cancer drug-matching. Hence, with rising demand for personalized medicine, which involves various proteomic technologies, is expected to drive the market over the forecast period.
Furthermore, the new acquisitions among the market players increase the research activities on proteomics, which is expected to boost the growth of the market. For instance, in December 2021, Insightful Science acquired Protein Metrics to expand its R&D solution to include proteomics. The acquisition expanded the company's R&D value chain to widen the biopharmaceutical protein analysis arena, unblocking data analysis bottlenecks currently associated with large-scale protein studies. Thus, the new company acquisitions help to expand the research and development for proteomics, which is expected to propel the growth of the market over the forecast period.
Thus, all the aforementioned factors, like new research developments in the field of proteomics and new partnerships and acquisitions among the market players, increase the widespread distribution of proteomics services, which is expected to boost the market growth over the forecast period. However, the high cost of instruments is expected to hinder the growth of the market over the forecast period.
North America Proteomics Market Trends
Drug Discovery is Expected to Witness Highest CAGR in the Market Over the Forecast Period
The proteomic approach to drug discovery involves identifying an unstable protein that is having a negative effect and employing a molecule to change that effect. The identification of potential new drugs for the treatment of disease has been considered one of the most promising developments in the study of human genes and proteins. This depends on genome and proteome information for the identification of proteins associated with a disease, which can then be used as targets for new drugs by computer software. The major factors that drive the segment to grow to include the increasing demand for advanced drug treatments and increasing funding for proteomic drug discovery research.
The establishment and launch of new proteomic technologies for various activities under drug discovery are expected to drive the market over the forecast period. For instance, in December 2022, Quantum-Si, the protein sequencing company, launched Platinum, a next-generation single-molecule protein sequencing platform. The elegant simplicity of this next-generation protein sequencing platform enables broad-scale access to proteomic data, positioning Platinum as a critical instrument for the future of proteomics research. This is expected to have a significant impact on the market over the forecast period.
Furthermore, in November 2022, Rezo was launched with a USD 78 million series, funding to advance the pipeline of precision therapeutics based on a groundbreaking integrated disease network mapping platform. Integration of technologies across proteomics, genetics, structural biology, chemistry, and bioinformatics enables advanced insights into disease biology for accelerated drug discovery. Hence, the new funding by the market players in drug discovery and proteomics help expand proteomics services, which is expected to drive the market over the forecast period.
Thus, the establishment of new technologies and new research funding for drug discovery with proteomics decrease the challenges in drug discovery, which is expected to have significant growth in the market over the forecast period.
United States is Expected to Have Significant Growth in the Market Over the Forecast Period
The United States is expected to hold a large market share, owing to the increasing research and development activities on drug discovery, technological advancements in proteomics, and increasing demand for personalized medicine in the country.
In addition, research funding for various proteomic techniques from government organizations is expected to drive the market over the forecast period in the country. For instance, in July 2021, the United States NIH funded a sum of USD 20 million for technology development in single-molecule and single-cell proteomics. This increases the research activities on proteomics in the country, which is expected to propel the growth of the market over the forecast period.
Furthermore, the new partnerships among the market players for the expansion of proteomic services are expected to have a significant impact on the market over the study period. For instance, in June 2022, Philips incorporated Biodesix blood-based proteomic nodule risk assessment testing into Lung Cancer Orchestrator to better assess the risk of lung nodule malignancy, enhancing decision-making for diagnosis and treatment. These partnerships among the companies increase the proteomic services for various applications, which are likely to boost the market growth in the country over the forecast period.
Therefore, the new funding for proteomic technology and new partnerships by market players increases the widespread distribution of proteomic services in the region, which is expected to have significant growth in the market over the forecast period.
North America Proteomics Industry Overview
The North American proteomics market is competitive, with the presence of several market players. The companies are involved in various strategies, such as new software launches and investments in research and development activities, to sustain themselves in the highly competitive environment. Companies like Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Merck KGaA, Promega Corporation, Thermo Fisher Scientific Inc., and Waters Corporation, among others, hold a substantial share in the proteomics market.
North America Proteomics Market Leaders
-
Agilent Technologies, Inc
-
Bio-Rad Laboratories, Inc
-
Thermo Fisher Scientific, Inc.
-
Danaher Corporation (Cytiva)
-
Merck KGaA (Sigma-Aldrich)
*Disclaimer: Major Players sorted in no particular order
North America Proteomics Market News
- January 2023: Bruker made a majority-ownership investment in Biognosys. With Bruker's investments, Biognosys plans to open advanced United States proteomics CRO facility for proteomics biomarker and drug discovery and development and pharmacoproteomics clinical trial support.
- May 2022: Ionpath received a strategic investment from Thermo Fisher Scientific to support spatial proteomics innovation.
North America Proteomics Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Demand for Personalized Medicine
- 4.2.2 Increasing R&D Expenditure and Government Funding for Proteomics
- 4.2.3 Technological Advancements
-
4.3 Market Restraints
- 4.3.1 High Cost of Instruments
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - in USD Millions)
-
5.1 By Type
- 5.1.1 Instrumentation Technology
- 5.1.1.1 Spectroscopy
- 5.1.1.2 Chromatography
- 5.1.1.3 Electrophoresis
- 5.1.1.4 Protein Microarrays
- 5.1.1.5 X-Ray Crystallography
- 5.1.1.6 Other Instrumentation Technologies
- 5.1.2 Services and Software
- 5.1.2.1 Core Proteomics Services
- 5.1.2.2 Bioinformatics Software and Services
- 5.1.3 Reagents
-
5.2 By Application
- 5.2.1 Clinical Diagnostics
- 5.2.2 Drug Discovery
- 5.2.3 Other Applications
-
5.3 By Geography
- 5.3.1 United States
- 5.3.2 Canada
- 5.3.3 Mexico
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Agilent Technologies Inc.
- 6.1.2 Bio-Rad Laboratories Inc.
- 6.1.3 Thermo Fisher Scientific Inc.
- 6.1.4 Danaher Corporation (Cytiva)
- 6.1.5 Merck KGaA (Sigma-Aldrich)
- 6.1.6 Bruker Corporation
- 6.1.7 Promega Corporation
- 6.1.8 Waters Corporation
- 6.1.9 Bruker Corporation
- 6.1.10 Dotmatics (Protein Metrics)
- 6.1.11 Creative Proteomics
- 6.1.12 Seer Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityNorth America Proteomics Industry Segmentation
As per the scope of the report, proteomics is the large-scale study of proteomes. A proteome is a set of proteins produced in an organism, system, or biological context. The North American proteomics market is segmented by type (instrumentation technology (spectroscopy, chromatography, electrophoresis, protein microarrays, X-Ray crystallography, and other instrumentation technologies), services and software (core proteomics services and bioinformatics software and services), and reagents), application (clinical diagnostics, drug discovery, and other applications), and geography (United States, Canada, and Mexico). The report offers values in USD million for all the above-mentioned segments.
| By Type | Instrumentation Technology | Spectroscopy |
| Chromatography | ||
| Electrophoresis | ||
| Protein Microarrays | ||
| X-Ray Crystallography | ||
| Other Instrumentation Technologies | ||
| By Type | Services and Software | Core Proteomics Services |
| Bioinformatics Software and Services | ||
| By Type | Reagents | |
| By Application | Clinical Diagnostics | |
| Drug Discovery | ||
| Other Applications | ||
| By Geography | United States | |
| Canada | ||
| Mexico |
North America Proteomics Market Research FAQs
What is the current North America Proteomics Market size?
The North America Proteomics Market is projected to register a CAGR of 12.5% during the forecast period (2024-2029)
Who are the key players in North America Proteomics Market?
Agilent Technologies, Inc, Bio-Rad Laboratories, Inc, Thermo Fisher Scientific, Inc., Danaher Corporation (Cytiva) and Merck KGaA (Sigma-Aldrich) are the major companies operating in the North America Proteomics Market.
What years does this North America Proteomics Market cover?
The report covers the North America Proteomics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Proteomics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
North America Proteomics Industry Report
Statistics for the 2024 North America Proteomics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. North America Proteomics analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
